Mesa Biotech is Diagnostic Equipment in United States that focus on current infectious disease business. Founded in 2009. They cover business area such as developer, infectious disease, revolutionary technology, convenience, procedural familiarity, traditional point, care rapid immunoassay, sensitivity, laboratory-base molecular testing, healthcare professional, actionable, laboratory-quality result, specificity.
2009
( 15 years old in 2024 )
Current Infectious Disease
-
6190 Cornerstone Court East
Suite 220
San Diego, CA 92121
United States
Private
developerinfectious diseaserevolutionary technologyconvenienceprocedural familiaritytraditional pointcare rapid immunoassaysensitivitylaboratory-base molecular testinghealthcare professionalactionable, laboratory-quality resultspecificity
* We use standard office opening hours in near Mesa Biotech's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Mesa Biotech is Diagnostic Equipment business from United States that founded in 2009 (15 years old in 2024), Mesa Biotech business is focusing on Current Infectious Disease.
Mesa Biotech headquarter office and corporate office address is located in 6190 Cornerstone Court East Suite 220 San Diego, CA 92121 United States.
Mesa Biotech was founded in United States.
In 2024, Mesa Biotech is currently focus on current infectious disease sector.
Above is snippet of Google Trends for "current infectious disease" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Mesa Biotech, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
